Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue.
暂无分享,去创建一个
Kai Fu | Raymond R Tubbs | Jan Delabie | Randy D Gascoyne | Timothy C Greiner | Chih-Jian Lih | David W Scott | Andreas Rosenwald | Elias Campo | Anja Mottok | L. Staudt | A. Rosenwald | W. Chan | T. Greiner | D. Weisenburger | K. Fu | R. Gascoyne | D. Scott | E. Campo | J. Connors | A. Mottok | George W. Wright | L. Rimsza | G. Ott | E. Jaffe | J. Delabie | E. Smeland | R. Braziel | David Steven Scott | P. M. Williams | C. Lih | R. Tubbs | W. Walsh | J. Cook | Louis M Staudt | P Mickey Williams | Joseph M Connors | B. Glinsmann-Gibson | Wing C Chan | German Ott | Lisa M Rimsza | Elaine S Jaffe | George W Wright | William Walsh | Erlend B Smeland | Rita M Braziel | James R Cook | Dennis D Weisenburger | Betty J Glinsmann-Gibson | D. Scott | P. Williams | George W. Wright | Raymond R. Tubbs | Elaine S. Jaffe | Wing C. Chan | G. W. Wright | P. M. Williams | E. Jaffe
[1] Sigrid Stroobants,et al. Revised response criteria for malignant lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Adrian Wiestner,et al. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[3] L. Staudt,et al. Targeting pathological B cell receptor signalling in lymphoid malignancies , 2013, Nature Reviews Drug Discovery.
[4] Kai Fu,et al. Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[6] Emili Montserrat,et al. A predictive model for aggressive non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.
[7] L. Staudt,et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. , 2004, Blood.
[8] E. Giné,et al. Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. , 2011, Blood.
[9] A. Rosenwald,et al. The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Jennifer L. Osborn,et al. Direct multiplexed measurement of gene expression with color-coded probe pairs , 2008, Nature Biotechnology.
[11] A Rosenwald,et al. Retracted: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium) , 2007, Journal of Clinical Pathology.
[12] L. Staudt,et al. Pathogenesis of human B cell lymphomas. , 2012, Annual review of immunology.
[13] Meland,et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.
[14] S. Barrans,et al. Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B‐cell lymphoma and predict clinical outcome , 2012, British journal of haematology.
[15] R. Spang,et al. Molecular classification of mature aggressive B-cell lymphoma using digital multiplexed gene expression on formalin-fixed paraffin-embedded biopsy specimens. , 2013, Blood.
[16] L. Staudt,et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.
[17] R. Advani,et al. Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] L. Staudt,et al. Stromal gene signatures in large-B-cell lymphomas. , 2008, The New England journal of medicine.
[19] A. Rosenwald,et al. Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP. , 2008, Blood.
[20] Kai Fu,et al. A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy , 2009, Clinical Cancer Research.
[21] L. Staudt,et al. Accurate Classification of Diffuse Large B-Cell Lymphoma into Germinal Center and Activated B-Cell Subtypes Using a Nuclease Protection Assay on Formalin-Fixed, Paraffin-Embedded Tissues , 2011, Clinical Cancer Research.
[22] L. Staudt,et al. using gene expression in formalin-fixed paraffin-embedded tissue Determining cell-of-origin subtypes of diffuse large B-cell lymphoma , 2014 .
[23] L. Staudt,et al. Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. , 2009, Blood.